Analyst Price Target is $2.00
▲ +614.29% Upside Potential
This price target is based on 0 analysts offering 12 month price targets for Streamline Health Solutions in the last 3 months. The average price target is $2.00, with a high forecast of $2.00 and a low forecast of $2.00. The average price target represents a 614.29% upside from the last price of $0.28.
Current Consensus is
The current consensus among 0 polled investment analysts is to n/a stock in Streamline Health Solutions. This N/A consensus rating has held steady for over two years.
Streamline Health Solutions, Inc. offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. The company offers RevID, an automated revenue reconciliation software; eValuator, a coding analysis platform; data comparison engine; coding and clinical documentation improvement (CDI) solutions, including CDI, abstracting, and physician query; and financial management solutions, such as accounts receivable management, denials management, claims processing, spend management, and audit management. It also provides auditing and coding, software, and professional services. The company sells its solutions and services through direct sales force and reseller partnerships. Streamline Health Solutions, Inc. was incorporated in 1989 and is based in Alpharetta, Georgia.